Basic Information
ID: ALA3888936
Type: Binding
Description: Transactivation Assay: The Notch-CBF1 (C-promoter binding factor I) cell based transactivation assay is based on the ability of the released Notch intracellular domain fragments (NICDs) to function as transcription factors in conjunction with CBF1 and other nuclear factors. Luciferase assays were used to measure the antagonism of Notch-CBF1 transcriptional activity. HeLa cervical cancer cells are transiently co-transfected with pCDNA3.1/Hygro plasmids containing truncated Notch 1, Notch 2, Notch 3, or Notch 4 receptors and a PGL3 luciferase reporter vector containing 4 copies of CBF1 binding site. The cells were then tested for Notch-CBF1 activity in the absence or presence of test compounds. HeLa cells, maintained in DMEM (high glucose with HEPES), 1× glutamine/penicillin/streptomycin and 10% Fetal Bovine serum, were transiently transfected in a T175 Flask (4.5×106 cells/flask) using the Monster Transfection Kit (Minis #MIR2906) according to manufacturers specifications.
Cell type: HeLa
Activity Charts
Bioactivity
Activity Types for Assay ALA3888936
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 462.59 | 3.51 | 3.51 |
| 568.54 | 4.42 | 4.42 |
| 590.95 | 5.22 | 5.22 |
| 574.50 | 4.71 | 4.71 |
| 572.96 | 5.07 | 5.07 |
| 495.02 | 3.94 | 3.94 |
| 540.95 | 4.38 | 4.38 |
| 488.63 | 4.06 | 4.06 |
| 536.53 | 3.74 | 3.74 |
| 511.07 | 4.55 | 4.55 |
| 537.51 | 2.98 | 2.98 |
| 590.59 | 5.29 | 5.29 |
| 550.53 | 4.41 | 4.41 |
| 546.57 | 4.57 | 4.57 |
| 582.55 | 4.86 | 4.86 |
| 638.61 | 5.48 | 5.48 |
| 590.95 | 5.22 | 5.22 |
| 599.00 | 5.38 | 5.38 |
| 568.52 | 4.55 | 4.55 |
| 524.49 | 4.02 | 4.02 |
| 564.56 | 4.72 | 4.72 |
| 599.00 | 5.46 | 5.46 |
| 631.02 | 6.00 | 6.00 |
| 580.55 | 4.42 | 4.42 |
| 606.59 | 4.96 | 4.96 |
| 536.50 | 4.02 | 4.02 |
| 584.97 | 5.07 | 5.07 |
| 582.55 | 4.86 | 4.86 |
| 594.58 | 4.81 | 4.81 |